J Genet Med.  2018 Jun;15(1):28-33. 10.5734/JGM.2018.15.1.28.

A novel GLA mutation in a Korean boy with an early cardiac manifestation of Fabry disease

• Kwon S
• Park JS
• Jung JH
• Hwang SK
• Kim YH
• Lee YJ

• KMID: 2435970
• DOI: http://doi.org/10.5734/JGM.2018.15.1.28

Abstract

Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by the deficiency of α-galactosidase A. Patients with classical FD present acroparesthesia, hypohidrosis, cornea verticillata, disseminated angiokeratoma, and microalbuminuria in childhood, and develop life-threatening renal, cardiac, and cerebrovascular complications typically after the fourth decade of life. To date, more than 700 mutations responsible for FD have been identified in the human GLA gene. Herein, we report a novel GLA mutation, c.1117_1141del25 (p.Gly373Profs*10), identified in an 11-year-old Korean boy with FD presenting early cardiac and neurologic manifestation and in other affected family members. The boy had acroparesthesia, hypohidrosis, cornea verticillata, and left ventricular hypertrophy. His mother and sister also had acroparesthesia. Two males on the mother's side had similar pain and died of unknown causes. The plasma α-galactosidase A activity (4.1 nmol/hr/mg protein) of the patient was markedly lower than the mean value of the controls. The plasma level of globotriaosylsphingosine was elevated in the patient and all the carriers. We concluded the novel GLA mutation c.1117_1141del25 is a pathogenic mutation for FD, probably related to the early cardiac manifestation of FD.

Keyword

Fabry disease; Lysosomal storage diseases; α-Galactosidase

MeSH Terms

Angiokeratoma
Child
Cornea
Fabry Disease*
Humans
Hypertrophy, Left Ventricular
Hypohidrosis
Lysosomal Storage Diseases
Male*
Mothers
Neurologic Manifestations
Plasma
Siblings